Abstract
Staphylococcus epidermidis is a usually harmless commensal bacterium highly abundant on the human skin. Under defined predisposing conditions, most importantly implantation of a medical device, S. epidermidis, however, can switch from a colonizing to an invasive life style. The emergence of S. epidermidis as an opportunistic pathogen is closely linked to the biofilm forming capability of the species. During the past decades, tremendous advance regarding our understanding of molecular mechanisms contributing to surface colonization has been made, and detailed information is available for several factors active during the primary attachment, accumulative or dispersal phase of biofilm formation. A picture evolved in which distinct factors, though appearing to be redundantly organized, take over specific and exclusive functions during biofilm development. In this review, these mechanisms are described in molecular detail, with a highlight on recent insights into multi-functional S. epidermidis cell surface proteins contributing to surface adherence and intercellular adhesion. The integration of distinct biofilm-promoting factors into regulatory networks is summarized, with an emphasis on mechanism that could allow S. epidermidis to flexibly adapt to changing environmental conditions present during colonizing or invasive life-styles.
Medical relevance of Staphylococcus epidermidis
Staphylococcus epidermidis, member of the group of coagulase-negative staphylococci, belongs to the commensal skin flora of every human individual (Kloos, , ; Kloos and Schleifer, ). In its natural niche, the species is of significant importance for maintenance of local homoeostasis—a role that is so far understood only superficially (Grice and Segre, ). Only recently light was shed onto the potential importance of S. epidermidis to interfere with colonization with Staphylococcus aureus via expression of a serine-type protease termed Esp, thereby interfering with colonization mechanisms of S. aureus, e.g., biofilm formation (Iwase et al., ; Sugimoto et al., 2013). Given the tremendous abundance of S. epidermidis on the skin, it is not surprising that S. epidermidis is the most common cause of contamination in clinical specimens, and it is a challenge for medical microbiologist to reliably identify true invasive isolates (Mack et al., ). Improved abilities to discriminate between clinically relevant and contaminating S. epidermidis isolates is of utmost importance, as the species is today one of the most important bacteria related to hospital acquired infections. If the invasive behavior of S. epidermidis follows a clear pathogenic strategy that extends its colonizing abilities (Mack et al., ), or merely can be regarded as an accident during which mechanisms usually contributing to commensalism turn into virulence features (Otto, ), is still a matter of debate. Nevertheless, without doubt S. epidermidis is a true opportunistic pathogen that only causes disease in patients with predisposing factors. These include individual patient characteristics (i.e., premature birth, congenital immune defects) or concomitant medical conditions—like HIV infection, immunosuppression after bone marrow or solid organ transplantation and chemotherapy related neutropenia (Goldmann and Pier, ; Rupp and Archer, 1994). Most significantly, S. epidermidis is the leading organism isolated from foreign material related infections (FMRI) (Darouiche, ; Geipel and Herrmann, ) such as infected prosthetic joints, central venous catheters (CVC), cerebrospinal fluid shunts, intracardiac devices, artificial heart valves, and vascular grafts (Mack et al., ; Rogers et al., 2009). Use of implanted medical devices increases in number, and certainly, this will further propel the importance of S. epidermidis as an important human pathogen.
S. epidermidis is responsible for the vast majority of nosocomial catheter related blood stream infections (CRBSI) in the United States (Wisplinghoff et al., 2003; Hidron et al., ) and also in German intensive care units (ICUs) (Geffers and Gastmeier, ). Evaluation of a multicenter international data collection calculated a risk of 6.8 CRBSI per 1000 central line-days in ICUs (Rosenthal et al., 2014). Results from the Surveillance and Control of Pathogens of Epidemiological Importance (SCOPE) indicate that coagulase-negative staphylococci are the most frequent cause of nosocomial blood stream infections (Wisplinghoff et al., 2003). Species discrimination identified eighty percent of CoNS from these infections as S. epidermidis (Jukes et al., ).
CoNS rank as third most common infective agent in native (NVIE) and first in prosthetic valve infective endocarditis (PVIE) clearly demonstrating the importance of CoNS in these clinical entities (Murdoch et al., ). Among CoNS isolates, about eighty percent were identified as S. epidermidis (Chu et al., , ). Evaluation of the results of the International Collaboration on Endocarditis database showed a significantly higher rate of complicated clinical courses of PVIE due to CoNS with respect to heart failure compared to S. aureus or viridans streptococci (Lalani et al., ).
S. epidermidis is a significant cause of infections of prosthetic joint implants. The lack of non-invasive curative treatment options for joint implant infections often necessitates surgical intervention including replacement surgery. In the UK, CoNS and S. epidermidis were isolated in 36% of total hip and 49% of total knee arthroplasty infections (Phillips et al., ; Nickinson et al., ). In another study of infected total hip and knee arthroplasties about 77% of the isolated CoNS were confirmed S. epidermidis (Rohde et al., 2007).
First evidence suggesting a pathogenetic link between foreign-material implantation and S. epidermidis infection came from early electron microscopic analysis of explanted central venous catheters. Here, bacteria were found to colonize artificial material in large agglomerations, embedded into an amorphous material (Peters et al., ). While this specific mode of growth was first referred to as “slime,” today it is termed biofilm formation (Götz, ). In fact, there is significant evidence connecting the biofilm mode of growth to the general persistent course of S. epidermidis foreign-material infections (Scherr et al., 2014a), and to the regular failure to eradicate infections by antimicrobial therapies (Lewis, ; Mack et al., ; Otto, ; Rohde et al., 2010). The latter aspect has been subject to extensive review recently (Lewis, ). Although S. epidermidis infections are regarded as prototypic biofilm infections (Costerton et al., ; Otto, ), it must be noted that it is by far not clear that biofilms observed under in vitro conditions indeed correlate with the biofilm growth evident in vivo. While this is most probably the case in central venous catheter (Peters et al., ) or cerebrospinal fluid shunt (Kockro et al., ) infections, there is some doubt that this model can be easily transferred to infections occurring at the interface of an implant and the surrounding tissues, e.g., prosthetic joint infections (Broekhuizen et al., ; Zaat et al., 2010). Clearly, much needs to be learned with regard to the exact spatial organization of S. epidermidis in implant infections, e.g., by making use of ex vivo or in vivo imaging approaches.
Structural factors contributing to S. epidermidis biofilm formation
Traditionally, the process of biofilm formation is divided into at least three steps. During the phase of primary attachment, bacteria adhere to the surface to be colonized, while during the accumulative phase, bacteria initiate the establishment of a three dimensional, multi-cellular and multi-layered architecture in which, intriguingly, most bacteria do not have direct contact to the surface (Mack et al., ; Otto, ; Rohde et al., 2010). S. epidermidis, then, is able to disassemble the biofilm structure again, and liberated cells are believed to allow S. epidermidis to colonize additional body sites. The process of biofilm formation needs a wide range of functional activities, ranging from molecules mediating binding to native or conditioned (i.e., host extracellular matrix covered) surfaces, over glue-like factors fostering cell-cell aggregation, to activities that break down matrix components (Otto, ). The tremendous diversity of specific functional requirements during biofilm formation is on the bacterial side significantly mirrored by the expression of a plethora of different, highly specialized factors characterized by very distinct profiles of biological functions. Thus, related to their specialized functions during S. epidermidis biofilm morphogenesis, specific factors are assigned to groups representing mechanisms being active either during primary attachment or during biofilm accumulation, respectively.
Factors involved in primary attachment
Tight binding of bacteria to foreign-materials is a pivotal step toward establishment of a device-associated infection. Not unexpectedly, factors specifically involved in mediating bacterial–surface interactions were identified and further characterized. Some genetic evidence suggests that bacterial binding to unmodified polystyrene is fostered by the S. epidermidis autolysin AtlE (Heilmann et al., ). AtlE is a 115 kDa protein, which belongs to a group of bacterial peptidoglycan (PGN)-hydrolases playing a pivotal role in the degradation of the bacterial cell wall (Biswas et al., ). The protein consists of an N-terminal signal peptide, a propeptide, a catalytic domain with N-acetylmuramyl-L-alanine amidase activity, three repeats (R1–3), and a C-terminal catalytic domain with N-acetylglucosaminidase activity (Schlag et al., 2010; Zoll et al., 2010). In addition to its general role in cell wall turnover, AtlE also is of importance for binding to unmodified polystyrene, as demonstrated by the defect of an atlE::Tn917 transposon mutant of S. epidermidis O-47 that lost its ability to adhere to plastic surfaces (Heilmann et al., ). Intriguingly, the importance of distinct domains for recruitment of AtlE to the bacterial cell wall (i.e., internal repeats) and enzymatic activities have been identified (Zoll et al., 2010). High resolution structural information is available, however so far it remains unclear, which exact AtlE domains are relevant for the primary attachment process and stable bacterial surface binding. In fact, at present it appears possible that expression and functional activation of AtlE induces significant changes in cell surface hydrophobicity, and thus, the AtlE effect on primary attachment might be secondary (Otto, ). In addition, a significant role of AtlE in eDNA mediated S. epidermidis biofilm formation is apparent (Qin et al., 2007; Christner et al., ).
While interactions between S. epidermidis and unmodified artificial surfaces most likely does not involve specific receptor-ligand interactions, it is well-known that S. epidermidis, similar to S. aureus, expresses cell surface proteins that mediate specific interactions with host extracellular matrix (ECM) components (Patti et al., ). Proteins with ECM-binding activity are believed to be of significant importance for the initiation of a device infection, since foreign materials become, as soon as they are inserted into the body, covered by ECM material (e.g., FN, fibronectin; Fg, fibrinogen; Vn, vitronectin; Cn, collagen) (Arrecubieta et al., ; Mack et al., ). In fact, S. epidermidis can use AtlE to adhere to surface organized Vn, while the lipase GehD is involved into interactions with collagen (Bowden et al., ). In addition to these proteins, for which their enzymatic activities might be of primary importance for S. epidermidis physiology, S. epidermidis also expresses proteins with a primary and dedicated function in bacterial-ECM interactions. These proteins belong to the group of serine-aspartate repeat (Sdr) proteins (McCrea et al., ), a widely investigated protein family of microbial surface components recognizing adhesive matrix molecules (MSCRAMM) (Josefsson et al., ; Foster et al., ). In S. epidermidis, three Sdr proteins referred to as SdrF, SdrG, and SdrH have been identified (Josefsson et al., ). SdrG, a LPXTG-motif containing protein covalently attached to the bacterial cell surface, is crucial for S. epidermidis adherence to fibrinogen-coated surfaces. It is therefore also being referred to as fibrinogen binding protein of S. epidermidis (Fbe) (Nilsson et al., ; Pei et al., ; Hartford et al., ). The gene encoding Fbe/SdrG is common in clinical S. epidermidis isolates (Nilsson et al., ; Rohde et al., 2004, 2007). Fbe/SdrG protein contains five distinct regions: an N-terminal export motif sequence, an A region that contains the Fg binding activity, a B region of so far unknown function, and the R region containing serine-aspartate repeat sequences. Fbe/SdrG specifically binds to a peptide sequence of 14 amino acids found in the N-terminus of the β-chain of Fg (Ponnuraj et al., 2003), and structural analysis of the interaction revealed a unique “dock, lock, and latch” mechanism ensuring a particularly strong interaction (Bowden et al., ; Herman et al., ). SdrF, sharing overall organizational similarity with SdrG, has been shown to mediate S. epidermidis binding to collagen I (Arrecubieta et al., ). In contrast to Fg-binding properties of Fbe/SdrG, the collagen binding epitopes of SdrF are located within the B repeat region (Arrecubieta et al., ). So far no specific functionality has been attributed to the N-terminal A domain of SdrF. A single B domain repeat of SdrF was sufficient to interact with collagen I, and apparently, this binding occurs via interactions with the α1 and α2 chains of type I collagen (Arrecubieta et al., ). Using a Lactococcus lactis heterologous expression system and a murine infection model evidence was generated that SdrF may contribute to cardiac assist device driveline infections (Arrecubieta et al., ). SdrF also mediates binding to unmodified Dacron surfaces covering drivelines. In contrast, L. lactis expressing GehD bound only weakly to driveline surfaces (Arrecubieta et al., ). Anti-SdrF inhibited S. epidermidis 9491 binding in the in vivo model only by roughly 50%, indicating that additional S. epidermidis collagen binding factors may be involved (Arrecubieta et al., ).
Extensive work has addressed the role of extracellular DNA (eDNA) in S. epidermidis and S. aureus biofilm formation. Data confirm that eDNA is a structural component of the biofilm matrix in both species, although evidence anticipates that eDNA has, at least partially, different functions in both species. Several independent studies have demonstrated that eDNA is released through increased cell lysis (Allesen-Holm et al., ; Rice et al., 2007; Christner et al., ). In S. epidermidis autolysis is determined to a large extent by the activity of the major autolysin AtlE (Biswas et al., ). A role for eDNA in S. epidermidis 1457 during primary attachment was deduced from observations showing that addition of DNase I abrogated bacterial attachment to glass surfaces. These findings were confirmed in additional, genetically independent S. epidermidis backgrounds (i.e., RP62A) (Qin et al., 2007). In extent to its effect on primary attachment, eDNA functions as an intercellular adhesin contributing to the stabilization of biofilms (Whitchurch et al., 2002). Based on the finding that DNase I has biofilm disintegrating activity when added within the first 6 h of biofilm accumulation currently it is believed that eDNA mediated intercellular adhesion is critical especially during the early accumulative phase (Qin et al., 2007). A role of eDNA in earlier stages of staphylococcal biofilm formation has recently been underpinned by observations showing that during S. aureus surface colonization under flow conditions eDNA, while not having impact on primary attachment, is critical during the transition from attachment to accumulation (Moormeier et al., ). It should again be stressed that functional differences of eDNA during S. epidermidis and S. aureus biofilm formation are apparent (especially with respect to the function during accumulation) (Izano et al., ; Christner et al., ), and observations in one species cannot easily be extrapolated to the other. This is especially true for the role of eDNA as a target during biofilm detachment events. By saeRS regulated expression of nuclease Nuc S. aureus can remodel the biofilm ultrastructure and control the release of bacteria from established biofilms (Mann et al., ; Olson et al., ). The lack of nuclease activity questions if this biofilm-escape mechanism is, in addition to agr-mediated biofilm dispersal (Vuong et al., 2003; Wang et al., 2011a), of relevance in S. epidermidis.
Mechanisms of S. epidermidis biofilm accumulation
The hallmark of the accumulative phase is expression of intercellular adhesive properties, ultimately leading to cell aggregation and subsequent development of a multicellular, multilayered biofilm architecture (Costerton et al., ). Parallel to the discovery of factors with dedicated functions during primary attachment, the nature of intercellular adhesins, functioning as the “biofilm glue,” was partially unraveled. Based on the early electron microscopic studies, showing S. epidermidis cells embedded in an amorphous extracellular matrix (Peters et al., ), focus was set onto the biochemical analysis of biofilm matrix components. These efforts ultimately resulted in the discovery of the polysaccharide intercellular adhesin (PIA), which is at present the most extensively studied intercellular adhesin (Mack et al., ).
Structural analysis of PIA and comparison of PIA isolated from S. epidermidis and S. aureus has been recently reviewed (Mack et al., ). The structure of PIA was first described for biofilm-forming S. epidermidis 1457 and RP62A. PIA was extracted from the cells by sonication after the strains had been cultured in trypticase soy broth, which revealed the existence of both a major polysaccharide I (>80%), and a minor polysaccharide II (<20%), which are structurally closely related and could be separated due to differing ionic properties (Mack et al., ). Chemical analyses and NMR spectroscopy have demonstrated that polysaccharide I is a linear homoglycan of β-1,6-linked 2-amino-2-deoxy-D-glucopyranosyl residues. Approximately 80–85% of them are N-acetylated; the rest are non-N-acetylated and carry a positive charge. Polysaccharide II of PIA has a lower proportion of de-N-acetylated 2-amino-2-deoxy-D-glucopyranosyl residues and is modified by ester-linked succinate residues rendering it anionic (Mack et al., ). Despite a high apparent molecular weight indicated by elution in the void volume of Sephadex G200 (Mack et al., , ) or Sephacryl S300 columns (C. Fischer and D. Mack, unpublished results), the ratio of reducing terminal sugar residues to total sugar residues was shown by methylation analysis to be 1:130, implying an average Mr of 30,000 for PIA polysaccharide chains (Mack et al., ). This implies aggregation of PIA polysaccharide chains in solution. PIA was shown to function also as the hemagglutinin of S. epidermidis (Rupp and Archer, 1992; Fey et al., ; Mack et al., ). Production of a functionally active PIA molecule requires expression of all four icaADBC genes (Gerke et al., ). The process has been the subject of detailed study in recombinant strains of S. carnosus which expressed different combinations of the icaADBC genes and with UDP-GlcNAc as a sugar donor (Gerke et al., ). IcaA belongs to the glycosyltransferase 2 family. It is an integral membrane protein with 412 aa and four predicted transmembrane domains (Heilmann et al., ; Gerke et al., ; Gill et al., ), and directs the synthesis of β-1,6-linked GlcNAc oligosaccharides of up to 20 GlcNAc units. IcaD is required for full activity of IcaA in vitro. It is a 101 aa integral membrane protein with two potential membrane spanning domains: it may be a chaperone directing folding and membrane insertion of IcaA and may act as a link between IcaA and IcaC (Gerke et al., ). Also essential for the synthesis of fully functioning PIA is IcaC, a 355 aa integral membrane protein with 10 predicted transmembrane domains, which may be involved in externalization and elongation of the growing polysaccharide (Gerke et al., ). IcaB is a member of the polysaccharide deacetylase family, including, for example, chitin deacetylases or the chitooligosaccharide deacetylase NodB of Rhizobium melioti. In its mature form it is a 259 aa secreted protein with a predicted signal sequence, responsible for the de-N-acetylation of PIA, and crucial for PIA activity in biofilm formation and for virulence in S. epidermidis (Vuong et al., 2004a). In ΔicaB-mutants, where the icaB gene has been deleted, PIA is poorly retained on the cell surface as it does not contain non-N-acetylated GlcNAc (Vuong et al., 2004a).
Early observations made by biochemical analysis of biofilm matrix extracts not only showed the presence of(poly-)saccharides but pointed toward the additional presence of proteins and nucleic acids (Hussain et al., ). Specific proteins have been identified and characterized. Apart from biofilm associated protein Bap (Tormo et al., 2005a), that is only rarely found in invasive S. epidermidis from human infections (Tormo et al., 2005a; Rohde et al., 2007; Piessens et al., 2012), SesC has been proposed to play a role in biofilm formation (Shahrooei et al., 2009). SesC is an LPXTG motif-containing 68 kDa surface protein of S. epidermidis distantly related to clumping factor A of S. aureus and is expressed more strongly in biofilm-associated as compared to planktonic S. epidermidis 1457 and 10b cells in vitro and in vivo (Shahrooei et al., 2009; Lam et al., ). Rabbit anti-SesC inhibited biofilm formation of a number of S. epidermidis isolates in vitro, which may be related to changes in primary attachment to fibrinogen-coated surfaces in the presence of anti-SesC. All of 105 S. epidermidis isolates recovered from nose swabs or infections were in possession of the sesC (Shahrooei et al., 2009). Passive and active immunization using SesC as a target protein was shown to decrease S. epidermidis biofilm formation in an in vivo model of central venous catheter infections (Shahrooei et al., 2012). A specific role of SesC as an intercellular adhesin in biofilm accumulation remains to be demonstrated.
Multifunctional protein factors in S. epidermidis biofilm formation
Although having partially additional enzymatic functions (e.g., AltE, GehD), it is a common feature of many factors contributing to S. epidermidis surface colonization that they carry out functions either during the primary attachment or accumulative phase of biofilm formation (Rohde et al., 2006; Mack et al., ; Otto, ). With the increasing interest in protein factors contributing to staphylococcal biofilm accumulation, it became apparent that, at least in S. aureus, many factors (e.g., FnBPA, ClfA) must be regarded as multifunctional proteins not having an exclusive role in either primary attachment or accumulation (Foster et al., ). This concept of multifunctional proteins with important roles during several phases of biofilm formation and surface colonization is now also evolving in S. epidermidis, with the accumulation associated protein (Aap) and the extracellular matrix binding protein (Embp) being the most prominent factors.
Embp and its ortholog in S. aureus designated Ebh were almost simultaneously identified during studies aiming at identifying S. epidermidis or S. aureus protein factors with Fn binding activities (Clarke et al., ; Williams et al., 2002). By using a phage display approach a phage was isolated, which exhibited fibronectin binding activity and contained a DNA fragment from a 30,500 bp open reading frame (ORF) coding for a 10,203 aa protein that was referred to as extracellular matrix binding protein Embp (Williams et al., 2002) (Figure 1). Using bioinformatics the architecture of Embp was predicted to consist of an N-terminal YSIRK-motif containing export signal (aa 58–84), followed by an unordered region of approximately 2500 amino acids (aa 85–2586). The overall architecture of Embp mainly is characterized by 21 repetitive “Found In Various Architectures” (FIVAR) repeats (aa 2587–4500) and 38 alternating “G-related Albumine-binding” (GA) motifs and FIVAR repeats—termed the FIVAR-GA repeats—(aa 4501–9443) that span roughly 7000 amino acids in the central proportion of the Embp protein. Finally the C-terminus consists of four domains of unknown function (DUF1542) (aa 9444–9841), followed by a potential transmembrane motive (aa 10,070–10,088) (Christner et al., ) (Figure 1). Although the S. aureus homolog Ebh displays at least functional homologies with respect to fibronectin binding activity (Clarke et al., ) some functional predictions found in Ebh, e.g., an N-terminal hyperosmolarity resistence domain (Kuroda et al., ; Tanaka et al., 2008) have not been identified in the Embp. The overall structural organization of the Ebh protein seems to be more or less identical to Embp, but in detail gradual differences are apparent, e.g., only seven FIVAR motifs but 12 additional FIVAR-GA repeats and four additional DUF1542 repeats compared to Embp were predicted (Tanaka et al., 2008). In fact, it appears that among different S. aureus strains the number of repetitive modules (FIVAR and FIVAR-GA) within Ebh is variable, while available sequence data shows no variability of these features in Embp from S. epidermidis RP62A, ATCC12228 or 1585.
Figure 1
Crystallization of two 126 amino acid FIVAR-GA repeats from EbhA of S. aureus MU50 (termed EbhA-R7-R8) revealed a triple α-helical structure interconnected by a continuous alpha helical string displaying an elongated shape (Sakamoto et al., 2008; Tanaka et al., 2008). In fact, the corresponding FIVAR-GA repeat of Embp exhibits a very similar, if not identical structure (Büttner, Perbandt, Rohde, unpublished results). Additional preliminary structural analysis of repetitive FIVAR regions (Büttner, Perband, Rohde, unpublished results) or DUF1542 repeats (Linke et al.,
In collections of clinical significant S. epidermidis isolates embp was detected in more than 90% of strains (Rohde et al., 2004, 2007). In addition, evidence for the expression of Embp in vivo resulted from investigations showing the presence of anti-Embp antibodies in patients with confirmed S. epidermidis prosthetic joint infections (Mack, Büttner, Rohde, unpublished). Strikingly, using a flow cell model of biofilm formation, anti-Embp antibodies were shown to inhibit S. epidermidis 1457 biofilm formation (Lam et al.,
Experimental evidence primarily suggested a role of Embp in primary attachment. Importantly, over-expression of Embp did not alter binding to unmodified polystyrene, but only boosted bacterial adherence to Fn-coated surfaces (Christner et al.,
In addition to its function in primary attachment, Embp is also functional as an intercellular adhesin. The intercellular adhesive properties and biofilm inducing activity of Embp was first detected in a laboratory derived strain S. epidermidis 1585v that, by a spontaneous chromosomal rearrangement, overexpressed a truncated isoform of Embp referred to as Embp1 (Christner et al.,
While at the time of its identification Embp appeared primarily as a factor mediating primary attachment, Aap was initially, and as already suggested by its designation, thought to confer intercellular adhesion and thereby to contribute to biofilm accumulation. Aap is a covalently linked, cell wall associated protein consisting of an A- and a B-domain (Rohde et al., 2005; Gruszka et al.,
Aap can be detected on the bacterial cell wall, where it is most likely retained by covalent linkage to the peptidoglycan via its C-terminal gram-positive anchor region (Hussain et al.,
The functional importance of Aap for S. epidermidis biofilm formation was first recognized during studies in which chemically derived, biofilm-negative mutant M7 of S. epidermidis RP62A was analyzed (Hussain et al.,
Importantly, expression of full length mature Aap is not sufficient to mediate intercellular adhesion during the second, accumulative phase of biofilm formation, but to become functionally active as an intercellular adhesin, Aap requires proteolytic processing, resulting in the removal of the A domain (Rohde et al., 2005; Geoghegan et al.,
Although the intercellular adhesive Aap properties were recognized first, there is now mounting evidence supporting a significant role of Aap also in primary attachment to natural epithelial cells or artificial surfaces (Macintosh et al.,
Molecular interactions and regulatory events during S. epidermidis biofilm formation
The detailed analysis of functional molecules contributing to S. epidermidis biofilm formation has clearly revealed that primary attachment as well as biofilm accumulation is mediated by redundantly organized factors with remarkable exclusive properties, but certainly broadly overlapping functional characteristics. The latter aspect is especially true for molecules active during the accumulative phase: production of PIA, Aap or Embp all efficiently induce cell aggregation, ultimately leading to assembly of a biofilm consortium. However, given the common observation that in clinical S. epidermidis isolates genes encoding for the PIA-synthesis machinery (icaADBC), aap, embp, and additional adherence-associated factors are all widely distributed, with a large percentage of strains carrying all three genes (Frebourg et al.,
Indeed, the idea that distinct S. epidermidis intercellular adhesins cooperate during biofilm assembly is supported by epidemiological work identifying that strains being positive for icaADBC and aap appear to form stronger biofilms compared to strains being positive only for icaADBC or aap (Stevens et al., 2008). Bioinformatic analysis of aap and embp indeed suggests that direct interaction with PIA might be possible. The G5 domains of the Aap B domain are postulated to have N-acetylglucosamine binding activity (Bateman et al.,
The interpretation of functional redundancy in intercellular adhesive molecules as a simple means allowing S. epidermidis to form as robust biofilms as possible, however, might be an inappropriate oversimplification of their actual functional importance during different S. epidermidis live styles, ranging between colonization and (foreign-material associated) host invasion. In that respect, it is important to acknowledge that a more detailed morphological analysis of PIA-, Aap- or Embp dependent biofilms revealed that these biofilm types differ significantly in their morphological properties. While in PIA-dependent biofilms, S. epidermidis cells are embedded into meshwork of PIA-containing extracellular matrix fibers, Aap production induces formation of densely packed cell layers that evenly cover the surface. In Embp-dependent biofilms, bacteria produce small amounts of Embp-containing extracellular matrix structures, however, these biofilms differ from PIA-dependent cell consortia by the lack of towers and clusters (Schommer et al., 2011). Overall, PIA-dependent biofilms are significantly more stable against washing procedures as compared to protein-dependent biofilms, indicating their inherent, pronounced mechanical robustness. Thus, the specific biological properties of a given intercellular adhesin could constitute a way how S. epidermidis can cope with varying challenges during colonization and infection (Schommer et al., 2011). Analysis of invasive S. epidermidis strains from various types of infections supports the idea that in fact, the ability to differentially make use of specific intercellular adhesins equips S. epidermidis to specifically adapt to changing environments with potential fundamentally different requirements, e.g., presence of mechanical or osmotic stress, or exposure to effectors of the host immune system (Otto,
Additional evidence suggesting that usage of specific intercellular adhesins indeed follows an adaptive program results from the observation that PIA-dependent biofilm formation on one hand, and Aap- and Embp-dependent biofilm formation on the other, are, at least under in vitro growth conditions, mutually exclusive (Rohde et al., 2005, 2007; Christner et al.,
More recently, in an attempt to shed light onto potential negative regulators interfering with biofilm formation in clinical S. epidermidis isolates under in vitro conditions, a transposon mutant library established in biofilm-negative S. epidermidis 1585 was screened for biofilm-positive mutants (Christner et al.,
The results of the study by Christner and co-workers appear to contradict previous findings, showing that SarA is a positive regulator of S. epidermidis biofilm formation by augmenting icaADBC expression (Tormo et al., 2005b; Handke et al.,
Figure 2

Schematic representation of SarA effects on expression of independent intercellular adhesins. While in trypticase soy broth, sarA is expressed, leading to icaADBC expression and PIA dependent biofilm formation, down-regulation of sarA leads to an de-repression of embp expression, allowing for maintenance of a biofilm-positive phenotype despite icaADBC down-regulation and loss of PIA production. Parallel to embp, following inactivation of sarA, metalloprotease sepA is up-regulated, leading to increased AtlE processing, autolysis and subsequent eDNA release. Potentially, the over-production of SepA also contributes to Aap-dependent biofilm accumulation by proteolytically processing of the mature protein, resulting in the removal of it's A domain. Environmental (potentially also host) factors that repress sarA expression are unknown, as are the pathways via which sarA itself is regulated.
Certainly, the highly artificial character of studies related to the function of SarA makes it difficult to draw general conclusions on the relevance of this mechanism during in vivo biofilm accumulation. In that respect, it becomes clearer that that more appropriate models of biofilm formation are generally needed in order to reflect the in vivo situation during infection and colonization. These models must take into account the potential inappropriateness of TSB as a growth medium that obviously introduces a significant bias toward PIA-dependent biofilm formation into the experimental system. The finding that embp, but also additional factors involved in S. epidermidis biofilm formation (e.g., Fbe/SdrG) are only expressed in the presence of serum (Sellman et al., 2005, 2008; Christner et al.,
Relevance of S. epidermidis biofilm formation for the pathogenesis of foreign-material associated infections in vivo
In general, studies aiming at elucidating the clinical relevance of biofilm formation and the relative contribution of specific factors to foreign-material colonization and establishment of a chronic persistent infection are either studied using cell culture models (Vuong et al., 2004a,c; Schommer et al., 2011), Caenorhabditis elegans (Begun et al.,
A significant reason for the impaired pathogenicity of icaADBC-negative mutants in animals models is the improved ability of the innate immune system to clear biofilm-negative S. epidermidis (Schommer et al., 2011). There is significant experimental evidence from cell culture assays that indeed biofilm positive strain 1457 was less susceptible to killing by antimicrobial peptides and also displayed decreased phagocytosis and killing by polymorphonuclear granulocytes (PMNs) compared to its isogenic icaA mutant 1457-M10 (Vuong et al., 2004c). When S. epidermidis 1457 was either grown in a static biofilm or planktonic culture, the organism grown in a biofilm was less susceptible to phagocytic killing after opsonisation with normal human serum, as was an isogenic biofilm-negative icaA-insertion mutant (Kristian et al.,
It is important to stress that, since S. epidermidis is an opportunistic pathogen, mechanisms of pathogenicity which are important in some types of device-related infection might be less crucial in others. For example, in the guinea pig tissue cage model (Zimmerli et al., 1982) there was no difference in virulence between a biofilm-positive wild-type S. epidermidis 1457 and its isogenic icaA-insertion mutant, and no difference between icaADBC-positive and -negative clinical isolates (Francois et al.,
S. epidermidis produces a number of pro-inflammatory peptides called phenol-soluble modulins (PSMs), which are produced in a strictly agr-controlled manner (Mehlin et al.,
Outlook and future directions
Over the past two decades, significant progress has been made in our understanding of the specific pathogenic nature of S. epidermidis in foreign material-associated infections. A molecular picture evolved showing that S. epidermidis virulence is linked to biofilm formation, a phenotype that depends on a wide variety of different factors which carry distinct and tightly regulated functions during surface colonization and interactions with host immune responses. Thus, S. epidermidis biofilm research has reached a turning point, at which on one hand additional in vitro evidence for the involvement of dedicated mechanisms in surface colonization can easily be accumulated, but on the other hand the question of the in vivo relevance of a given factor or process certainly arises. Thus, a major future challenge will be to translate findings from highly artificial, simple in vitro biofilm analysis systems into complex (organ-) models that more appropriately reflect the in vivo infection settings. Moreover, it is of urgent importance to validate findings from in vitro models in relevant animal models of device infections. These approaches should involve not only state of the art molecular biology, biochemical and immunological methods but also time-resolved in vivo and ex vivo imaging technologies, allowing to create a more distinct picture of the invasive S. epidermidis life style in different and extremely variable environmental conditions. Using the new armament of technologies, including three-dimensional cell culture techniques and tissue engineering, efforts are necessary to study the role of S. epidermidis as a beneficial skin commensal more intensively.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
Allesen-HolmM.BarkenK. B.YangL.KlausenM.WebbJ. S.KjellebergS.et al. (2006). A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol. 59, 1114–1128. 10.1111/j.1365-2958.2005.05008.x
2
ArciolaC. R.CampocciaD.GamberiniS.RizziS.DonatiM. E.BaldassarriL.et al. (2004). Search for the insertion element IS256 within the ica locus of Staphylococcus epidermidis clinical isolates collected from biomaterial-associated infections. Biomaterials25, 4117–4125. 10.1016/j.biomaterials.2003.11.027
3
ArrecubietaC.AsaiT.BayernM.LoughmanA.FitzgeraldJ. R.SheltonC. E.et al. (2006). The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J. Infect. Dis. 193, 1109–1119. 10.1086/501366
4
ArrecubietaC.LeeM. H.MaceyA.FosterT. J.LowyF. D. (2007). SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J. Biol. Chem. 282, 18767–18776. 10.1074/jbc.M610940200
5
ArrecubietaC.TobaF. A.von BayernM.AkashiH.DengM. C.NakaY.et al. (2009). SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections. PLoS. Pathog. 5:e1000411. 10.1371/journal.ppat.1000411
6
BannerM. A.CunniffeJ. G.MacintoshR. L.FosterT. J.RohdeH.MackD.et al. (2007). Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein. J. Bacteriol. 189, 2793–2804. 10.1128/JB.00952-06
7
BatemanA.HoldenM. T.YeatsC. (2005). The G5 domain: a potential N-acetylglucosamine recognition domain involved in biofilm formation. Bioinformatics21, 1301–1303. 10.1093/bioinformatics/bti206
8
BatzillaC. F.RachidS.EngelmannS.HeckerM.HackerJ.ZiebuhrW. (2006). Impact of the accessory gene regulatory system (Agr) on extracellular proteins, codY expression and amino acid metabolism in Staphylococcus epidermidis. Proteomics6, 3602–3613. 10.1002/pmic.200500732
9
BegunJ.GaianiJ. M.RohdeH.MackD.CalderwoodS. B.AusubelF. M.et al. (2007). Staphylococcal biofilm exopolysaccharide protects against Caenorhabditis elegans immune defenses. PLoS. Pathog. 3:e57. 10.1371/journal.ppat.0030057
10
BinghamR. J.Rudino-PineraE.MeenanN. A.Schwarz-LinekU.TurkenburgJ. P.HookM.et al. (2008). Crystal structures of fibronectin-binding sites from Staphylococcus aureus FnBPA in complex with fibronectin domains. Proc. Natl. Acad. Sci. U.S.A. 105, 12254–12258. 10.1073/pnas.0803556105
11
BiswasR.VogguL.SimonU. K.HentschelP.ThummG.GotzF. (2006). Activity of the major staphylococcal autolysin Atl. FEMS Microbiol. Lett. 259, 260–268. 10.1111/j.1574-6968.2006.00281.x
12
BowdenM. G.HeuckA. P.PonnurajK.KolosovaE.ChoeD.GurusiddappaS.et al. (2008). Evidence for the “dock, lock, and latch” ligand binding mechanism of the staphylococcal microbial surface component recognizing adhesive matrix molecules (MSCRAMM) SdrG. J. Biol. Chem. 283, 638–647. 10.1074/jbc.M706252200
13
BowdenM. G.VisaiL.LongshawC. M.HollandK. T.SpezialeP.HookM. (2002). Is the GehD lipase from Staphylococcus epidermidis a collagen binding adhesin?J. Biol. Chem. 277, 43017–43023. 10.1074/jbc.M207921200
14
BroekhuizenC. A.SchultzM. J.van der WalA. C.BoszhardL.de BoerL.Vandenbroucke-GraulsC. M.et al. (2008). Tissue around catheters is a niche for bacteria associated with medical device infection. Crit. Care Med. 36, 2395–2402. 10.1097/CCM.0b013e3181818268
15
BustanjiY.ArciolaC. R.ContiM.MandelloE.MontanaroL.SamoriB. (2003). Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force. Proc. Natl. Acad. Sci. U.S.A. 100, 13292–13297. 10.1073/pnas.1735343100
16
ChagnotC.ListratA.AstrucT.DesvauxM. (2012). Bacterial adhesion to animal tissues: protein determinants for recognition of extracellular matrix components. Cell. Microbiol. 14, 1687–1696. 10.1111/cmi.12002
17
ChengA. G.MissiakasD.SchneewindO. (2014). The giant protein Ebh is a determinant of Staphylococcus aureus cell size and complement resistance. J. Bacteriol. 196, 971–981. 10.1128/JB.01366-13
18
CheungG. Y.RigbyK.WangR.QueckS. Y.BraughtonK. R.WhitneyA. R.et al. (2010). Staphylococcus epidermidis strategies to avoid killing by human neutrophils. PLoS. Pathog. 6:e1001133. 10.1371/journal.ppat.1001133
19
ChokrA.LetermeD.WatierD.JabbouriS. (2007). Neither the presence of ica locus, nor in vitro-biofilm formation ability is a crucial parameter for some Staphylococcus epidermidis strains to maintain an infection in a guinea pig tissue cage model. Microb. Pathog. 42, 94–97. 10.1016/j.micpath.2006.09.001
20
ChristnerM.FrankeG. C.SchommerN. N.WendtU.WegertK.PehleP.et al. (2010). The giant extracellular matrix-binding protein of Staphylococcus epidermidis mediates biofilm accumulation and attachment to fibronectin. Mol. Microbiol. 75, 187–207. 10.1111/j.1365-2958.2009.06981.x
21
ChristnerM.HeinzeC.BuschM.FrankeG.HentschkeM.BayardD. S.et al. (2012). sarA negatively regulates Staphylococcus epidermidis biofilm formation by modulating expression of 1 MDa extracellular matrix binding protein and autolysis-dependent release of eDNA. Mol. Microbiol. 86, 394–410. 10.1111/j.1365-2958.2012.08203.x
22
ChuV. H.CabellC. H.AbrutynE.CoreyG. R.HoenB.MiroJ. M.et al. (2004). Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the International Collaboration on Endocarditis Merged Database. Clin. Infect. Dis. 39, 1527–1530. 10.1086/424878
23
ChuV. H.MiroJ. M.HoenB.CabellC. H.PappasP. A.JonesP.et al. (2009). Coagulase-negative staphylococcal prosthetic valve endocarditis–a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study. Heart95, 570–576. 10.1136/hrt.2008.152975
24
ClarkeS. R.HarrisL. G.RichardsR. G.FosterS. J. (2002). Analysis of Ebh, a 1.1-megadalton cell wall-associated fibronectin-binding protein of Staphylococcus aureus. Infect. Immun. 70, 6680–6687. 10.1128/IAI.70.12.6680-6687.2002
25
ConlonB. P.GeogheganJ. A.WatersE. M.McCarthyH.RoweS. E.DaviesJ. R.et al. (2014). Role for the A domain of unprocessed accumulation-associated protein (Aap) in the attachment phase of the Staphylococcus epidermidis biofilm phenotype. J. Bacteriol. 196, 4268–4275. 10.1128/JB.01946-14
26
ConlonK. M.HumphreysH.O'GaraJ. P. (2002). Regulation of icaR gene expression in Staphylococcus epidermidis. FEMS Microbiol. Lett. 216, 171–177. 10.1111/j.1574-6968.2002.tb11432.x
27
ConradyD. G.BresciaC. C.HoriiK.WeissA. A.HassettD. J.HerrA. B. (2008). A zinc-dependent adhesion module is responsible for intercellular adhesion in staphylococcal biofilms. Proc. Natl. Acad. Sci. U.S.A. 105, 19456–19461. 10.1073/pnas.0807717105
28
ConradyD. G.WilsonJ. J.HerrA. B. (2013). Structural basis for Zn2+-dependent intercellular adhesion in staphylococcal biofilms. Proc. Natl. Acad. Sci. U.S.A. 110, E202–E211. 10.1073/pnas.1208134110
29
CostertonJ. W.LewandowskiZ.CaldwellD. E.KorberD. R.Lappin-ScottH. M. (1995). Microbial biofilms. Annu. Rev. Microbiol. 49, 711–745. 10.1146/annurev.mi.49.100195.003431
30
CostertonJ. W.StewartP. S.GreenbergE. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science284, 1318–1322. 10.1126/science.284.5418.1318
31
CueD.LeiM. G.LeeC. Y. (2012). Genetic regulation of the intercellular adhesion locus in staphylococci. Front Cell Infect. Microbiol. 2:38. 10.3389/fcimb.2012.00038
32
DaboS. M.ConferA. W.AndersonB. E.GuptaS. (2006). Bartonella henselae Pap31, an extracellular matrix adhesin, binds the fibronectin repeat III13 module. Infect. Immun. 74, 2513–2521. 10.1128/IAI.74.5.2513-2521.2006
33
DarouicheR. O. (2004). Treatment of infections associated with surgical implants. N. Engl. J. Med. 350, 1422–1429. 10.1056/NEJMra035415
34
FeyP. D.UlphaniJ. S.GötzF.HeilmannC.MackD.RuppM. E. (1999). Characterization of the relationship between polysaccharide intercellular adhesin and hemagglutination in Staphylococcus epidermidis. J. Infect. Dis. 179, 1561–1564. 10.1086/314762
35
FluckigerU.UlrichM.SteinhuberA.DoringG.MackD.LandmannR.et al. (2005). Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model. Infect. Immun. 73, 1811–1819. 10.1128/IAI.73.3.1811-1819.2005
36
FluckigerU.WolzC.CheungA. L. (1998). Characterization of a sar homolog of Staphylococcus epidermidis. Infect. Immun. 66, 2871–2878.
37
FosterT. J.GeogheganJ. A.GaneshV. K.HookM. (2014). Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 12, 49–62. 10.1038/nrmicro3161
38
FrancoisP.Tu QuocP. H.BisognanoC.KelleyW. L.LewD. P.SchrenzelJ.et al. (2003). Lack of biofilm contribution to bacterial colonisation in an experimental model of foreign body infection by Staphylococcus aureus and Staphylococcus epidermidis. FEMS Immunol. Med. Microbiol. 35, 135–140. 10.1016/S0928-8244(02)00463-7
39
FrebourgN. B.LefebvreS.BaertS.LemelandJ. F. (2000). PCR-Based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J. Clin. Microbiol. 38, 877–880.
40
GaldbartJ. O.AllignetJ.TungH. S.RydenC.ElS. N. (2000). Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prostheses. J. Infect. Dis. 182, 351–355. 10.1086/315660
41
GeffersC.GastmeierP. (2011). Nosocomial infections and multidrug-resistant organisms in Germany: epidemiological data from KISS (the Hospital Infection Surveillance System). Dtsch. Arztebl. Int. 108, 87–93. 10.3238/arztebl.2011.0087
42
GeipelU.HerrmannM. (2005). The infected implant: bacteriology. Unfallchirurg108, 961–975.
43
GeogheganJ. A.CorriganR. M.GruszkaD. T.SpezialeP.O'GaraJ. P.PottsJ. R.et al. (2010). Role of surface protein SasG in biofilm formation by Staphylococcus aureus. J. Bacteriol. 192, 5663–5673. 10.1128/JB.00628-10
44
GerkeC.KraftA.SüssmuthR.SchweitzerO.GötzF. (1998). Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J. Biol. Chem. 273, 18586–18593. 10.1074/jbc.273.29.18586
45
GillS. R.FoutsD. E.ArcherG. L.MongodinE. F.DeboyR. T.RavelJ.et al. (2005). Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187, 2426–2438. 10.1128/JB.187.7.2426-2438.2005
46
GoldmannD. A.PierG. B. (1993). Pathogenesis of infections related to intravascular catheterization. Clin. Microbiol. Rev. 6, 176–192.
47
GötzF. (2002). Staphylococcus and biofilms. Mol. Microbiol. 43, 1367–1378. 10.1046/j.1365-2958.2002.02827.x
48
GötzF. (2004). Staphylococci in colonization and disease: prospective targets for drugs and vaccines. Curr. Opin. Microbiol. 7, 477–487. 10.1016/j.mib.2004.08.014
49
GriceE. A.SegreJ. A. (2011). The skin microbiome. Nat. Rev. Microbiol. 9, 244–253. 10.1038/nrmicro2537
50
GruszkaD. T.WojdylaJ. A.BinghamR. J.TurkenburgJ. P.ManfieldI. W.StewardA.et al. (2012). Staphylococcal biofilm-forming protein has a contiguous rod-like structure. Proc. Natl. Acad. Sci. U.S.A. 109, E1011–E1018. 10.1073/pnas.1119456109
51
HandkeL. D.SlaterS. R.ConlonK. M.O'DonnellS. T.OlsonM. E.BryantK. A.et al. (2007). SigmaB and SarA independently regulate polysaccharide intercellular adhesin production in Staphylococcus epidermidis. Can. J. Microbiol. 53, 82–91. 10.1139/w06-108
52
HartfordO.O'BrienL.SchofieldK.WellsJ.FosterT. J. (2001). The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen. Microbiology147, 2545–2552.
53
HeilmannC.HussainM.PetersG.GötzF. (1997). Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol. Microbiol. 24, 1013–1024. 10.1046/j.1365-2958.1997.4101774.x
54
HeilmannC.SchweitzerO.GerkeC.VanittanakomN.MackD.GötzF. (1996). Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20, 1083–1091. 10.1111/j.1365-2958.1996.tb02548.x
55
HermanP.El-Kirat-ChatelS.BeaussartA.GeogheganJ. A.FosterT. J.DufreneY. F. (2014). The binding force of the staphylococcal adhesin SdrG is remarkably strong. Mol. Microbiol. 93, 356–368. 10.1111/mmi.12663
56
HidronA. I.EdwardsJ. R.PatelJ.HoranT. C.SievertD. M.PollockD. A.et al. (2008). NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29, 996–1011. 10.1086/591861
57
HussainM.HastingsJ. G.WhiteP. J. (1991). Isolation and composition of the extracellular slime made by coagulase-negative staphylococci in a chemically defined medium. J. Infect. Dis. 163, 534–541. 10.1093/infdis/163.3.534
58
HussainM.HerrmannM.von EiffC.Perdreau-RemingtonF.PetersG. (1997). A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces. Infect. Immun. 65, 519–524.
59
IwaseT.UeharaY.ShinjiH.TajimaA.SeoH.TakadaK.et al. (2010). Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature465, 346–349. 10.1038/nature09074
60
IzanoE. A.AmaranteM. A.KherW. B.KaplanJ. B. (2008). Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl. Environ. Microbiol. 74, 470–476. 10.1128/AEM.02073-07
61
JosefssonE.McCreaK. W.NiE. D.O'ConnellD.CoxJ.HookM.et al. (1998). Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology144(Pt 12), 3387–3395. 10.1099/00221287-144-12-3387
62
JukesL.MikhailJ.Bome-MannathokoN.HadfieldS. J.HarrisL. G.El-BouriK.et al. (2010). Rapid differentiation of Staphylococcus aureus, Staphylococcus epidermidis and other coagulase-negative staphylococci and meticillin susceptibility testing directly from growth-positive blood cultures by multiplex real-time PCR. J. Med. Microbiol. 59, 1456–1461. 10.1099/jmm.0.023168-0
63
KaplanJ. B.RagunathC.VelliyagounderK.FineD. H.RamasubbuN. (2004). Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob. Agents Chemother. 48, 2633–2636. 10.1128/AAC.48.7.2633-2636.2004
64
KingsleyR. A.KeestraA. M.de ZoeteM. R.BaumlerA. J. (2004). The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding. Mol. Microbiol. 52, 345–355. 10.1111/j.1365-2958.2004.03995.x
65
KloosW. E. (1980). Natural populations of the genus Staphylococcus. Annu. Rev. Microbiol. 34, 559–592. 10.1146/annurev.mi.34.100180.003015
66
KloosW. E. (1997). Taxonomy and systematics of staphylococci indigenous to humans in The Staphylococci in Human Disease, eds CrossleyK. B.ArcherG. L.. (New York, NY: Churchill Livingston), 113–137.
67
KloosW. E.SchleiferK. H. (1986). Genus IV. Staphylococcus, in Bergey's Manual of Systematic Bacteriology, Vol. 2, ed SneathH. A. (Baltimore, MD: Williams and Wilkins), 1013–1035.
68
KlugD.WalletF.KacetS.CourcolR. J. (2003). Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections. J. Clin. Microbiol. 41, 3348–3350. 10.1128/JCM.41.7.3348-3350.2003
69
KnoblochJ. K.JagerS.HorstkotteM. A.RohdeH.MackD. (2004). RsbU-dependent regulation of Staphylococcus epidermidis biofilm formation is mediated via the alternative sigma factor sigmaB by repression of the negative regulator gene icaR. Infect. Immun. 72, 3838–3848. 10.1128/IAI.72.7.3838-3848.2004
70
KnoblochJ. K. M.BartschtK.SabottkeA.RohdeH.FeuchtH. H.MackD. (2001). Biofilm formation of Staphylococcus epidermidis depends on RsbU, a functional activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress. J. Bacteriol. 183, 2624–2633. 10.1128/JB.183.8.2624-2633.2001
71
KockroR. A.HamplJ. A.JansenB.PetersG.ScheihingM.GiacomelliR.et al. (2000). Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters. J. Med. Microbiol. 49, 441–450.
72
KrismerB.LiebekeM.JanekD.NegaM.RautenbergM.HornigG.et al. (2014). Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose. PLoS. Pathog. 10:e1003862. 10.1371/journal.ppat.1003862
73
KristianS. A.BirkenstockT. A.SauderU.MackD.GötzF.LandmannR. (2008). Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J. Infect. Dis. 197, 1028–1035. 10.1086/528992
74
KurodaM.TanakaY.AokiR.ShuD.TsumotoK.OhtaT. (2008). Staphylococcus aureus giant protein Ebh is involved in tolerance to transient hyperosmotic pressure. Biochem. Biophys. Res. Commun. 374, 237–241. 10.1016/j.bbrc.2008.07.037
75
LaiY.VillaruzA. E.LiM.ChaD. J.SturdevantD. E.OttoM. (2007). The human anionic antimicrobial peptide dermcidin induces proteolytic defence mechanisms in staphylococci. Mol. Microbiol. 63, 497–506. 10.1111/j.1365-2958.2006.05540.x
76
LalaniT.KanafaniZ. A.ChuV. H.MooreL.CoreyG. R.PappasP.et al. (2006). Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database. Eur. J. Clin. Microbiol. Infect. Dis. 25, 365–368. 10.1007/s10096-006-0141-z
77
LamH.KessellyA.StegalkinaS.KleanthousH.YethonJ. A. (2014). Antibodies to PhnD inhibit staphylococcal biofilms. Infect. Immun. 82, 3764–3774. 10.1128/IAI.02168-14
78
LewisK. (2005). Persister cells and the riddle of biofilm survival. Biochemistry (Mosc.)70, 267–274. 10.1007/s10541-005-0111-6
79
LewisK. (2010). Persister cells. Annu. Rev. Microbiol. 64, 357–372. 10.1146/annurev.micro.112408.134306
80
LiH.XuL.WangJ.WenY.VuongC.OttoM.et al. (2005). Conversion of Staphylococcus epidermidis strains from commensal to invasive by expression of the ica locus encoding production of biofilm exopolysaccharide. Infect. Immun. 73, 3188–3191. 10.1128/IAI.73.5.3188-3191.2005
81
LinkeC.SiemensN.OehmckeS.RadjainiaM.LawR. H.WhisstockJ. C.et al. (2012). The extracellular protein factor Epf from Streptococcus pyogenes is a cell surface adhesin that binds to cells through an N-terminal domain containing a carbohydrate-binding module. J. Biol. Chem. 287, 38178–38189. 10.1074/jbc.M112.376434
82
LouQ.ZhuT.HuJ.BenH.YangJ.YuF.et al. (2011). Role of the SaeRS two-component regulatory system in Staphylococcus epidermidis autolysis and biofilm formation. BMC Microbiol. 11:146. 10.1186/1471-2180-11-146
83
MacintoshR. L.BrittanJ. L.BhattacharyaR.JenkinsonH. F.DerrickJ.UptonM.et al. (2009). The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes. J. Bacteriol. 191, 7007–7016. 10.1128/JB.00764-09
84
MackD.BeckerP.ChatterjeeI.KnoblochJ. K. M.PetersG.RohdeH.et al. (2004). Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int. J. Med. Microbiol. 294, 203–212. 10.1016/j.ijmm.2004.06.015
85
MackD.DaviesA. P.HarrisL. G.JeevesR.PascoeB.KnoblochJ. K. M.et al. (2013). Staphylococcus epidermidis in biomaterial associated infections, in Biomaterials Associated Infections: Immunological Aspects and Antimicrobial Strategies, eds MoriatryT. F.ZaatS. A.BusscherH. J. (New York, NY: Springer), 25–56.
86
MackD.DaviesA. P.HarrisL. G.KnoblochJ. K.RohdeH. (2009). Staphylococcus epidermidis biofilms: functional molecules, relation to virulence, and vaccine potential. Top. Curr. Chem. 288, 157–182. 10.1007/128_2008_19
87
MackD.FischerW.KrokotschA.LeopoldK.HartmannR.EggeH.et al. (1996). The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178, 175–183.
88
MackD.HorstkotteM. A.RohdeH.KnoblochJ. K. M. (2006). Coagulase-negative staphylococci, in Biofilms, Infection, and Antimicrobial Therapy, eds PaceJ. L.RuppM. E.FinchR. G. (Boca Raton, FL: CRC Press), 109–153.
89
MackD.NedelmannM.KrokotschA.SchwarzkopfA.HeesemannJ.LaufsR. (1994a). Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect. Immun. 62, 3244–3253.
90
MackD.RiedewaldJ.RohdeH.MagnusT.FeuchtH. H.ElsnerH. A.et al. (1999). Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination. Infect. Immun. 67, 1004–1008.
91
MackD.SiemssenN.LaufsR. (1994b). Identification of a cell cluster associated antigen specific for plastic-adherent Staphylococcus epidermidis which is functional related to intercellular adhesion. Zentralbl. Bakteriol. Suppl. 26, 411–413.
92
MannE. E.RiceK. C.BolesB. R.EndresJ. L.RanjitD.ChandramohanL.et al. (2009). Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PloS ONE4:e5822. 10.1371/journal.pone.0005822
93
McCreaK. W.HartfordO.DavisS.EidhinD. N.LinaG.SpezialeP.et al. (2000). The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology146(Pt 7), 1535–1546.
94
MeenanN. A.VisaiL.ValtulinaV.Schwarz-LinekU.NorrisN. C.GurusiddappaS.et al. (2007). The tandem beta-zipper model defines high affinity fibronectin-binding repeats within Staphylococcus aureus FnBPA. J. Biol. Chem. 282, 25893–25902. 10.1074/jbc.M703063200
95
MehlinC.HeadleyC. M.KlebanoffS. J. (1999). An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization. J. Exp. Med. 189, 907–918. 10.1084/jem.189.6.907
96
MonkA. B.ArcherG. L. (2007). Use of outer surface protein repeat regions for improved genotyping of Staphylococcus epidermidis. J. Clin. Microbiol. 45, 730–735. 10.1128/JCM.02317-06
97
MonkA. B.BoundyS.ChuV. H.BettingerJ. C.RoblesJ. R.FowlerV. G.Jr.et al. (2008). Analysis of the genotype and virulence of Staphylococcus epidermidis isolates from patients with infective endocarditis. Infect. Immun. 76, 5127–5132. 10.1128/IAI.00606-08
98
MoormeierD. E.BoseJ. L.HorswillA. R.BaylesK. W. (2014). Temporal and stochastic control of Staphylococcus aureus biofilm development. MBio5:e01341-14. 10.1128/mBio.01341-14
99
MurdochD. R.CoreyG. R.HoenB.MiroJ. M.FowlerV. G.Jr.BayerA. S.et al. (2009). Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern. Med. 169, 463–473. 10.1001/archinternmed.2008.603
100
NickinsonR. S.BoardT. N.GambhirA. K.PorterM. L.KayP. R. (2010). The microbiology of the infected knee arthroplasty. Int. Orthop. 34, 505–510. 10.1007/s00264-009-0797-y
101
NilssonM.FrykbergL.FlockJ. I.PeiL.LindbergM.GussB. (1998). A fibrinogen-binding protein of Staphylococcus epidermidis. Infect. Immun. 66, 2666–2673.
102
OdekerkenJ. C.ArtsJ. J.SurtelD. A.WalenkampG. H.WeltingT. J. (2013). A rabbit osteomyelitis model for the longitudinal assessment of early post-operative implant infections. J. Orthop. Surg. Res. 8, 38. 10.1186/1749-799X-8-38
103
OhnemusU.KohrmeyerK.HoudekP.RohdeH.WladykowskiE.VidalS.et al. (2007). Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J. Invest. Dermatol.
104
OlsonM. E.NygaardT. K.AckermannL.WatkinsR. L.ZurekO. W.PallisterK. B.et al. (2013). Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor. Infect. Immun. 81, 1316–1324. 10.1128/IAI.01242-12
105
OlsonM. E.ToddD. A.SchaefferC. R.PaharikA. E.Van DykeM. J.ButtnerH.et al. (2014). The Staphylococcus epidermidis agr quorum-sensing system: signal identification, cross talk, and importance in colonization. J. Bacteriol. 196, 3482–3493. 10.1128/JB.01882-14
106
OttoM. (2009). Staphylococcus epidermidis–the ‘accidental’ pathogen. Nat. Rev. Microbiol. 7, 555–567. 10.1038/nrmicro2182
107
OttoM. (2014). Physical stress and bacterial colonization. FEMS Microbiol. Rev. 38, 1250–1270. 10.1111/1574-6976.12088
108
PattiJ. M.AllenB. L.McGavinM. J.HöökM. (1994). MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48, 585–617. 10.1146/annurev.mi.48.100194.003101
109
PeiL.PalmaM.NilssonM.GussB.FlockJ. I. (1999). Functional studies of a fibrinogen binding protein from Staphylococcus epidermidis. Infect. Immun. 67, 4525–4530.
110
PetersG.LocciR.PulvererG. (1981). Microbial colonization of prosthetic devices. II. Scanning electron microscopy of naturally infected intravenous catheters. Zentralbl. Bakteriol. Mikrobiol. Hyg. B173, 293–299.
111
PetersG.LocciR.PulvererG. (1982). Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J. Infect. Dis. 146, 479–482. 10.1093/infdis/146.4.479
112
PetrelliD.ZampaloniC.D'ErcoleS.PrennaM.BallariniP.RipaS.et al. (2006). Analysis of different genetic traits and their association with biofilm formation in Staphylococcus epidermidis isolates from central venous catheter infections. Eur. J. Clin. Microbiol. Infect. Dis. 25, 773–781. 10.1007/s10096-006-0226-8
113
PhillipsJ. E.CraneT. P.NoyM.ElliottT. S.GrimerR. J. (2006). The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J. Bone Joint Surg. Br. 88, 943–948. 10.1302/0301-620X.88B7.17150
114
PiessensV.De VliegherS.VerbistB.BraemG.Van NuffelA.De VuystL.et al. (2012). Characterization of coagulase-negative staphylococcus species from cows' milk and environment based on bap, icaA, and mecA genes and phenotypic susceptibility to antimicrobials and teat dips. J. Dairy Sci. 95, 7027–7038. 10.3168/jds.2012-5400
115
PonnurajK.BowdenM. G.DavisS.GurusiddappaS.MooreD.ChoeD.et al. (2003). A “dock, lock, and latch” structural model for a staphylococcal adhesin binding to fibrinogen. Cell. 115, 217–228. 10.1016/S0092-8674(03)00809-2
116
QinZ.OuY.YangL.ZhuY.Tolker-NielsenT.MolinS.et al. (2007). Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology. 153, 2083–2092. 10.1099/mic.0.2007/006031-0
117
RiceK. C.MannE. E.EndresJ. L.WeissE. C.CassatJ. E.SmeltzerM. S.et al. (2007). The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc. Natl. Acad. Sci. U.S.A. 104, 8113–8118. 10.1073/pnas.0610226104
118
RogersK. L.FeyP. D.RuppM. E. (2009). Coagulase-negative staphylococcal infections. Infect. Dis. Clin. North Am. 23, 73–98. 10.1016/j.idc.2008.10.001
119
RohdeH.BurandtE. C.SiemssenN.FrommeltL.BurdelskiC.WursterS.et al. (2007). Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials28, 1711–1720. 10.1016/j.biomaterials.2006.11.046
120
RohdeH.BurdelskiC.BartschtK.HussainM.BuckF.HorstkotteM. A.et al. (2005). Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol. Microbiol. 55, 1883–1895. 10.1111/j.1365-2958.2005.04515.x
121
RohdeH.FrankenbergerS.ZähringerU.MackD. (2010). Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur. J. Cell Biol. 89, 103–111. 10.1016/j.ejcb.2009.10.005
122
RohdeH.KalitzkyM.KrogerN.ScherpeS.HorstkotteM. A.KnoblochJ. K.et al. (2004). Detection of virulence-associated genes not useful for discriminating between invasive and commensal Staphylococcus epidermidis strains from a bone marrow transplant unit. J. Clin. Microbiol. 42, 5614–5619. 10.1128/JCM.42.12.5614-5619.2004
123
RohdeH.MackD.ChristnerM.BurdelskiC.FrankeG. C.KnoblochJ. K. (2006). Pathogenesis of staphylococcal device-related infections: from basic science to new diagnostic, therapeutic and prophylactic approaches. Rev. Med. Microbiol. 17, 45–54. 10.1097/01.revmedmi.0000244134.43170.83
124
RosenthalV. D.MakiD. G.MehtaY.LeblebiciogluH.MemishZ. A.Al-MousaH. H.et al. (2014). International Nosocomial Infection Control Consortium (INICC) report, data summary of 43 countries for 2007–2012. Device-associated module. Am. J. Infect. Control. 42, 942–956. 10.1016/j.ajic.2014.05.029
125
RuppM. E.ArcherG. L. (1992). Hemagglutination and adherence to plastic by Staphylococcus epidermidis. Infect. Immun. 60, 4322–4327.
126
RuppM. E.ArcherG. L. (1994). Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19, 231–243. 10.1093/clinids/19.2.231
127
RuppM. E.FeyP. D.HeilmannC.GötzF. (2001). Characterization of the importance of Staphylococcus epidermidis autolysin and polysaccharide intercellular adhesin in the pathogenesis of intravascular catheter-associated infection in a rat model. J. Infect. Dis. 183, 1038–1042. 10.1086/319279
128
RuppM. E.UlphaniJ. S.FeyP. D.BartschtK.MackD. (1999a). Characterization of the importance of polysaccharide intercellular adhesin/hemagglutinin of Staphylococcus epidermidis in the pathogenesis of biomaterial-based infection in a mouse foreign body infection model. Infect. Immun. 67, 2627–2632.
129
RuppM. E.UlphaniJ. S.FeyP. D.MackD. (1999b). Characterization of Staphylococcus epidermidis polysaccharide intercellular adhesin/hemagglutinin in the pathogenesis of intravascular catheter-associated infection in a rat model. Infect. Immun. 67, 2656–2659.
130
SadykovM. R.HartmannT.MattesT. A.HiattM.JannN. J.ZhuY.et al. (2011). CcpA coordinates central metabolism and biofilm formation in Staphylococcus epidermidis. Microbiology157, 3458–3468. 10.1099/mic.0.051243-0
131
SakamotoS.TanakaY.TanakaI.TakeiT.YuJ.KurodaM.et al. (2008). Electron microscopy and computational studies of Ebh, a giant cell-wall-associated protein from Staphylococcus aureus. Biochem. Biophys. Res. Commun. 376, 261–266. 10.1016/j.bbrc.2008.08.117
132
SchaefferC. R.WoodsK. M.LongoG. M.KiedrowskiM. R.PaharikA. E.ButtnerH.et al. (2015). Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model. Infect. Immun. 83, 214–226. 10.1128/IAI.02177-14
133
ScherrT. D.HeimC. E.MorrisonJ. M.KielianT. (2014a). Hiding in plain sight: interplay between Staphylococcal biofilms and host immunity. Front Immunol. 5:37. 10.3389/fimmu.2014.00037
134
ScherrT. D.LindgrenK. E.SchaefferC. R.HankeM. L.HartmanC. W.KielianT. (2014b). Mouse model of post-arthroplasty Staphylococcus epidermidis joint infection. Methods Mol. Biol. 1106, 173–181. 10.1007/978-1-62703-736-5_16
135
SchlagM.BiswasR.KrismerB.KohlerT.ZollS.YuW.et al. (2010). Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol. Microbiol. 75, 864–873. 10.1111/j.1365-2958.2009.07007.x
136
SchommerN. N.ChristnerM.HentschkeM.RuckdeschelK.AepfelbacherM.RohdeH. (2011). Staphylococcus epidermidis uses distinct mechanisms of biofilm formation to interfere with phagocytosis and activation of mouse macrophage-like cells 774A.1. Infect. Immun. 79, 2267–2276. 10.1128/IAI.01142-1
137
SellmanB. R.HowellA. P.Kelly-BoydC.BakerS. M. (2005). Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect. Immun. 73, 6591–6600. 10.1128/IAI.73.10.6591-6600.2005
138
SellmanB. R.TimofeyevaY.NanraJ.ScottA.FulginitiJ. P.MatsukaY. V.et al. (2008). Expression of Staphylococcus epidermidis SdrG increases following exposure to an in vivo environment. Infect. Immun. 76, 2950–2957. 10.1128/IAI.00055-08
139
ShahrooeiM.HiraV.KhodaparastL.KhodaparastL.StijlemansB.KucharikovaS.et al. (2012). Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation. Infect. Immun. 80, 3660–3668. 10.1128/IAI.00104-12
140
ShahrooeiM.HiraV.StijlemansB.MerckxR.HermansP. W.Van EldereJ. (2009). Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. Infect. Immun. 77, 3670–3678. 10.1128/IAI.01464-08
141
StevensN. T.TharmabalaM.DillaneT.GreeneC. M.O'GaraJ. P.HumphreysH. (2008). Biofilm and the role of the ica operon and aap in Staphylococcus epidermidis isolates causing neurosurgical meningitis. Clin. Microbiol. Infect. 14, 719–722. 10.1111/j.1469-0691.2008.02012.x
142
SugimotoS.IwamotoT.TakadaK.OkudaK.TajimaA.IwaseT.et al. (2013). Staphylococcus epidermidis Esp degrades specific proteins associated with Staphylococcus aureus biofilm formation and host-pathogen interaction. J. Bacteriol. 195, 1645–1655. 10.1128/JB.01672-12
143
TanakaY.SakamotoS.KurodaM.GodaS.GaoY. G.TsumotoK.et al. (2008). A helical string of alternately connected three-helix bundles for the cell wall-associated adhesion protein Ebh from Staphylococcus aureus. Structure16, 488–496. 10.1016/j.str.2007.12.018
144
ThomasV. C.HiromasaY.HarmsN.ThurlowL.TomichJ.HancockL. E. (2009). A fratricidal mechanism is responsible for eDNA release and contributes to biofilm development of Enterococcus faecalis. Mol. Microbiol. 72, 1022–1036. 10.1111/j.1365-2958.2009.06703.x
145
ThomasV. C.ThurlowL. R.BoyleD.HancockL. E. (2008). Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J. Bacteriol. 190, 5690–5698. 10.1128/JB.00314-08
146
TormoM. A.KnechtE.GötzF.LasaI.PenadesJ. R. (2005a). Bap-dependent biofilm formation by pathogenic species of Staphylococcus: evidence of horizontal gene transfer?Microbiology151, 2465–2475. 10.1099/mic.0.27865-0
147
TormoM. A.MartiM.ValleJ.MannaA. C.CheungA. L.LasaI.et al. (2005b). SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development. J. Bacteriol. 187, 2348–2356. 10.1128/JB.187.7.2348-2356.2005
148
VuongC.GerkeC.SomervilleG. A.FischerE. R.OttoM. (2003). Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J. Infect. Dis. 188, 706–718. 10.1086/377239
149
VuongC.KocianovaS.VoyichJ. M.YaoY.FischerE. R.DeLeoF. R.et al. (2004a). A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem. 279, 54881–54886. 10.1074/jbc.M411374200
150
VuongC.KocianovaS.YaoY.CarmodyA. B.OttoM. (2004b). Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J. Infect. Dis. 190, 1498–1505. 10.1086/424487
151
VuongC.VoyichJ. M.FischerE. R.BraughtonK. R.WhitneyA. R.DeLeoF. R.et al. (2004c). Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol. 6, 269–275. 10.1046/j.1462-5822.2004.00367.x
152
WangR.KhanB. A.CheungG. Y.BachT. H.Jameson-LeeM.KongK. F.et al. (2011a). Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J. Clin. Invest. 121, 238–248. 10.1172/JCI42520
153
WangX.NiuC.SunG.DongD.VillaruzA. E.LiM.et al. (2011b). ygs is a novel gene that influences biofilm formation and the general stress response of Staphylococcus epidermidis. Infect. Immun. 79, 1007–1015. 10.1128/IAI.00916-10
154
WhitchurchC. B.Tolker-NielsenT.RagasP. C.MattickJ. S. (2002). Extracellular DNA required for bacterial biofilm formation. Science295, 1487. 10.1126/science.295.5559.1487
155
WilliamsR. J.HendersonB.SharpL. J.NairS. P. (2002). Identification of a Fibronectin-Binding Protein from Staphylococcus epidermidis. Infect. Immun. 70, 6805–6810. 10.1128/IAI.70.12.6805-6810.2002
156
WisplinghoffH.SeifertH.TallentS. M.BischoffT.WenzelR. P.EdmondM. B. (2003). Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr. Infect. Dis. J. 22, 686–691. 10.1097/01.inf.0000078159.53132.40
157
WuY.WuY.ZhuT.HanH.LiuH.XuT.et al. (2015). Staphylococcus epidermidis SrrAB regulates bacterial growth and biofilm formation differently under oxic and microaerobic conditions. J. Bacteriol. 197, 459–476. 10.1128/JB.02231-14
158
XuL.LiH.VuongC.VadyvalooV.WangJ.YaoY.et al. (2006). Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect. Immun. 74, 488–496. 10.1128/IAI.74.1.488-496.2006
159
YaoY.SturdevantD. E.VillaruzA.XuL.GaoQ.OttoM. (2005). Factors characterizing Staphylococcus epidermidis invasiveness determined by comparative genomics. Infect. Immun. 73, 1856–1860. 10.1128/IAI.73.3.1856-1860.2005
160
ZaatS.BroekhuizenC.RioolM. (2010). Host tissue as a niche for biomaterial-associated infection. Future Microbiol. 5, 1149–1151. 10.2217/fmb.10.89
161
ZiebuhrW.HeilmannC.GötzF.MeyerP.WilmsK.StraubeE.et al. (1997). Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect. Immun. 65, 890–896.
162
ZimmerliW.LewP. D.WaldvogelF. A. (1984). Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J. Clin. Invest. 73, 1191–1200. 10.1172/JCI111305
163
ZimmerliW.WaldvogelF. A.VaudauxP.NydeggerU. E. (1982). Pathogenesis of foreign body infection: description and characteristics of an animal model. J. Infect. Dis. 146, 487–497. 10.1093/infdis/146.4.487
164
ZollS.PatzoldB.SchlagM.GotzF.KalbacherH.StehleT. (2010). Structural basis of cell wall cleavage by a staphylococcal autolysin. PLoS. Pathog. 6:e1000807. 10.1371/journal.ppat.1000807
Summary
Keywords
Staphylococcus epidermidis biofilm formation, regulation, PIA, Aap, Embp, AtlE, primary attachment, biofilm accumulation
Citation
Büttner H, Mack D and Rohde H (2015) Structural basis of Staphylococcus epidermidis biofilm formation: mechanisms and molecular interactions. Front. Cell. Infect. Microbiol. 5:14. doi: 10.3389/fcimb.2015.00014
Received
15 December 2014
Accepted
26 January 2015
Published
17 February 2015
Volume
5 - 2015
Edited by
Pietro Speziale, University degli Studi di Pavia, Italy
Reviewed by
Chia Lee, University of Arkansas for Medical Sciences, USA; Carla Renata Arciola, Rizzoli Orthopaedic Institute, Italy
Copyright
© 2015 Büttner, Mack and Rohde.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Holger Rohde, Institut für Medizinische Mikrobiologie, Virologie und Hygiene, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany e-mail: rohde@uke.de
This article was submitted to the journal Frontiers in Cellular and Infection Microbiology.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.